Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors

COVID-19 has caused a severe global pandemic. Until now, there has been no simple and reliable system available in a lower-biosafety-grade laboratory for SARS-CoV-2 virologic research and inhibitor screening.

Guardado en:
Detalles Bibliográficos
Autores principales: Yuewen Luo, Fei Yu, Mo Zhou, Yang Liu, Baijin Xia, Xiantao Zhang, Jun Liu, Junsong Zhang, Yingying Du, Rong Li, Liyang Wu, Xu Zhang, Ting Pan, Deyin Guo, Tao Peng, Hui Zhang
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/d5c00aed9d414a1f927a51605da20f00
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!